Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthieu Canuet

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
American Journal of Respiratory and Critical Care Medicine|November 17, 2007
Procoagulant membrane microparticles correlate with the severity of pulmonary arterial hypertensionBabe Bakouboula, Olivier Morel, Antoine Faure, et al.
The European Respiratory Journal|February 12, 2013
Pulmonary hypertension in antisynthetase syndrome: prevalence, aetiology and survivalBaptiste Hervier, Alain Meyer, Céline Dieval, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 28, 2016
Brief Report: Spatial Heterogeneity of Systemic Sclerosis in France: High Prevalence in the Northeast RegionAlain Meyer, Hélène Chifflot, Emmanuel Chatelus, et al.
The European Respiratory Journal|September 21, 2019
Clinical phenotypes and outcomes of precapillary pulmonary hypertension of sickle cell diseaseLaurent Savale, Anoosha Habibi, François Lionnet, et al.
Circulation|March 28, 2012
Pulmonary arterial hypertension in patients treated by dasatinibDavid Montani, Emmanuel Bergot, Sven Günther, et al.
The Lancet. Respiratory Medicine|August 4, 2022
Balloon pulmonary angioplasty versus riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (RACE): a multicentre, phase 3, open-label, randomised controlled trial and ancillary follow-up studyXavier Jaïs, Philippe Brenot, Hélène Bouvaist, et al.
Lupus Science & Medicine|June 13, 2025
Pulmonary arterial hypertension in systemic lupus erythematosus: identification of risk factors and haemodynamics characteristics in a multicentre retrospective cohortEmiliano Marasco, Christina Düsing, Stefanie Keymel, et al.
Journal of Neurology|March 5, 2021
Biallelic RFC1-expansion in a French multicentric sporadic ataxia cohortSolveig Montaut, Nadège Diedhiou, Pauline Fahrer, et al.
Annals of the Rheumatic Diseases|September 2, 2015
A prospective study of the 6 min walk test as a surrogate marker for haemodynamics in two independent cohorts of treatment-naïve systemic sclerosis-associated pulmonary arterial hypertensionSébastien Sanges, David Launay, Rennie L Rhee, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
American Journal of Respiratory and Critical Care Medicine|November 17, 2007
Procoagulant membrane microparticles correlate with the severity of pulmonary arterial hypertensionBabe Bakouboula, Olivier Morel, Antoine Faure, et al.
The European Respiratory Journal|February 12, 2013
Pulmonary hypertension in antisynthetase syndrome: prevalence, aetiology and survivalBaptiste Hervier, Alain Meyer, Céline Dieval, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 28, 2016
Brief Report: Spatial Heterogeneity of Systemic Sclerosis in France: High Prevalence in the Northeast RegionAlain Meyer, Hélène Chifflot, Emmanuel Chatelus, et al.
The European Respiratory Journal|September 21, 2019
Clinical phenotypes and outcomes of precapillary pulmonary hypertension of sickle cell diseaseLaurent Savale, Anoosha Habibi, François Lionnet, et al.
Circulation|March 28, 2012
Pulmonary arterial hypertension in patients treated by dasatinibDavid Montani, Emmanuel Bergot, Sven Günther, et al.
The Lancet. Respiratory Medicine|August 4, 2022
Balloon pulmonary angioplasty versus riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (RACE): a multicentre, phase 3, open-label, randomised controlled trial and ancillary follow-up studyXavier Jaïs, Philippe Brenot, Hélène Bouvaist, et al.
Lupus Science & Medicine|June 13, 2025
Pulmonary arterial hypertension in systemic lupus erythematosus: identification of risk factors and haemodynamics characteristics in a multicentre retrospective cohortEmiliano Marasco, Christina Düsing, Stefanie Keymel, et al.
Journal of Neurology|March 5, 2021
Biallelic RFC1-expansion in a French multicentric sporadic ataxia cohortSolveig Montaut, Nadège Diedhiou, Pauline Fahrer, et al.
Annals of the Rheumatic Diseases|September 2, 2015
A prospective study of the 6 min walk test as a surrogate marker for haemodynamics in two independent cohorts of treatment-naïve systemic sclerosis-associated pulmonary arterial hypertensionSébastien Sanges, David Launay, Rennie L Rhee, et al.
Pageof 4